Price, Matthew J.
Brigham and Women's Hospital · Beth Israel Deaconess Medical Center · Inserm · Columbia University Irving Medical Center · Assistance Publique – Hôpitaux de Paris · Kerckhoff Klinik · Laboratoire de Recherche Vasculaire Translationnelle · Stanford Medicine · Cardiovascular Research Foundation · Hôpital Bichat-Claude-Bernard · Scripps Clinic · Medicines Company (United States) · Université Paris Diderot · Stanford University
5 papers on CoChatORCID 0000-0002-7892-2430
Most cited papers
- Verified
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding
Tantry, U. S., Bonello, L., Aradi, D., Price, M. J., Jeong, Y.-H., Angiolillo, D. J., Stone, G. W., Curzen, N., Geisler, T., ten Berg, J., et al. (2013) · Journal of the American College of Cardiology
Antiplatelet Therapy and Cardiovascular DiseasesPlatelet Disorders and Treatments
Cited by 910
- Verified
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
Price, M. J., Endemann, S., Gollapudi, R. R., Valencia, R., Stinis, C. T., Levisay, J. P., Ernst, A., Sawhney, N. S., Schatz, R. A., & Teirstein, P. S. (2008) · European Heart Journal
Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics
Cited by 651
- Verified
Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation
Holmes, D. R., Doshi, S. K., Kar, S., Price, M. J., Sanchez, J. M., Sievert, H., Valderrabano, M., & Reddy, V. Y. (2015) · Journal of the American College of Cardiology
Atrial Fibrillation Management and OutcomesCardiovascular and Diving-Related Complications
Cited by 543
- Verified
Predictors of Heightened Platelet Reactivity Despite Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
Price, M. J., Nayak, K. R., Barker, C. M., Kandzari, D. E., & Teirstein, P. S. (2009) · The American Journal of Cardiology
Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics
Cited by 145
- Verified
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial
Vaduganathan, M., Harrington, R. A., Stone, G. W., Steg, P. G., Gibson, C. M., Hamm, C. W., Price, M. J., Prats, J., Deliargyris, E. N., Mahaffey, K. W., et al. (2016) · Circulation: Cardiovascular Interventions
Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free